Furthermore, the DNA damage repair-associated inhibitors ATR/ATM in combination with ARID1A-deficiency or BAF complex -inhibition functionally synergize, suggesting a potential synthetic lethal strategy to target tumor cells [199,200]. This evidence concerns the gene ARID1A and neoplasm.